This article is only for the reference of medical and pharmaceutical professionals practicing in Chinese mainland, if you are not the aforementioned professional, please leave this page
审批码：PP-FR-CN-1267
bibliography
[1] Liang Kang, et al. 2024 ASCO. Rapid Oral Abstract Session #3516.
[2] Zhenyu Lin, et al. 2024 ASCO. #LBA3606.
[3] Michael Brian LaPelusa, et al. 2024 ASCO. #3612.
[4] Marwan Fakih, et al. 2024 ASCO. Rapid Oral Abstract Session #LBA3510.
[5] Xicheng Wang, et al. 2024 ASCO. #LBA3559.
[6] Heinz-Josef Lenz, et al. 2024 ASCO. Oral Abstract Session#3503.
[7] Weijian Guo, et al. 2024 ASCO. #3578.
[8] Feng Wang, et al. 2024 ASCO. #3569.
[9] 2024 CSCO结直肠癌诊疗指南.
[10] Abrams TA, et al. J Natl Cancer Inst. 2014; 106(2):djt371.
[11] Sun Q,et al. Cancer Biol Ther. 2014; 15(12):1635-45.
[12] Li J, et al. JAMA. 2018 Jun 26; 319(24):2486-2496.
[13] Xu R, et al. Future Oncol. 2021 Apr; 17(11):1339-1350.
[14] Qin S, et al. Onco Targets Ther. 2021 Aug 11;14:4439-4450.
[15] Arvind Dasari, et al. 2022 ESMO,LBA 25.
[16] Fruquintinib drug insert.
[17]https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fruquintinib-refractory-metastatic-colorectal-cancer
[18] NCCN Clinical Practice Guidelines in Oncology. Colon Cancer.2024 v1.
[19] NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer.2024 v1.
[20] National Catalogue of Drugs for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (2023).
Fruquintinib Fact Sheet:
This article is intended to provide scientific information to healthcare professionals only and does not represent the position of the platform
审批码：PP-FR-CN-1266
Approval time: July 24, 2024
✩ This article is for the reference of medical and health professionals only
Reviewer: Babel
Typography: Babel
Executive: Babel
This platform aims to deliver more medical information to healthcare professionals. The content published on this platform should not be used as a substitute for professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice. If such information is used for purposes other than understanding medical information, the platform does not assume relevant responsibilities. This platform does not mean that it agrees with its descriptions and views on the published content. If copyright issues are involved, please contact us, and we will deal with it as soon as possible.